FDA Approves Kirsty (insulin aspart-xjhz), an Interchangeable ...
Kirsty is a rapid-acting human insulin analog indicated to improve glycemic control in adults and pediatric patients with diabetes mellitus. Kirsty will be available as a single-patient-use prefilled pen for …
KIRSTY - accessdata.fda.gov
Use KIRSTY in accordance with the insulin pump system’s instructions for use. Train patients using continuous subcutaneous insulin fusion pump therapy to administer insulin by injection and have...
Kirsty (Insulin aspart-xjhz Injection): Side Effects, Uses ... - RxList
Aug 19, 2025 · Kirsty for injection: 100 units/mL (U-100) is a clear and colorless solution available as a 10 mL multiple-dose vial and a 3 mL single-patient-use prefilled pen. The safety and effectiveness of …
FDA Approves Kirsty as First Interchangeable Insulin Aspart Biosimilar
Jul 15, 2025 · The FDA has approved Kirsty, the first interchangeable insulin aspart biosimilar, enhancing access to affordable diabetes care for millions.
Can use this KIRSTY product with the continuous subcutaneous insulin infusion pumps labeled for use with KIRSTY or NOVOLOG. Refer to the insulin pump user manual to see if KIRSTY or NOVOLOG …
Kirsty (insulin aspart): Uses, Side Effects, Dosage & Reviews
Learn about Kirsty (insulin aspart) usage and dosing. Read the latest news and reviews about the drug as well as potential side effects and popular alternatives.
Kirsty: Package Insert / Prescribing Information / MOA
Sep 18, 2025 · Kirsty package insert / prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions and pharmacology.
Kirsty - Wikipedia
Kirsty or Kirstie is a feminine given name and nickname. [1][2] It is a Scottish diminutive of Christine in English-speaking countries and is also linked to Kirsten — the Scandinavian version of Christine.
FDA approves Biocon BLA for Kirsty | The Pharmaletter
Jul 16, 2025 · The US Food and Drug Administration has approved the first rapid-acting interchangeable biosimilar product, Kirsty (insulin aspart-xjhz), as a 3 mL single-patient-use prefilled pen and 10 mL …
Kirsty, an Interchangeable Biosimilar to Novolog, Gets FDA Approval
Jul 17, 2025 · The FDA has approved Kirsty (insulin aspart-xjhz), an interchangeable biosimilar to Novolog, to improve glycemic control in diabetes mellitus.